Kido G, Wright J L, Merchant R E
Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond.
J Neurooncol. 1991 Apr;10(2):95-109. doi: 10.1007/BF00146870.
The effects of intravenous (IV) infusion of human recombinant tumor necrosis factor-alpha (rTNF-alpha, Cetus) on normal brain and malignant glioma in rats were examined. Twelve Fischer 344 rats were given either a single injection of 10(6) U rTNF-alpha or injections of 5 x 10(5) U rTNF-alpha for three days. One day post-rTNF-alpha injection(s), rats were injected IV with horseradish peroxidase (HRP) to determine blood-brain barrier (BBB) breakdown and, one hour later, were perfused with an aldehyde fixative and processed for histologic examination. Treatment of normal rats with rTNF-alpha by either dosage or schedule caused no remarkable histopathologic changes in the brain and no alteration in BBB integrity. Human glioma models were produced by intracerebal inoculation of 10(4) syngeneic RT-2 glioma cells into the right parietal lobe of 30 rats. Animals received single IV injections of 10(6) U human rTNF-alpha or its excipient (TNF-E) as above on day 3, 7, or 10 post-tumor inoculation or multiple injections of 5 x 10(5) U rTNF-alpha beginning on day 7, 10, or 12 post-tumor inoculation. With a single IV injection of either rTNF-alpha or its excipient, 3-day models showed a similar pattern of HRP extravasation limited to the extracellular space of the tumor inoculation site. In 7-day models treated with a single IV injection of rTNF-alpha or TNF-E, HRP extravasated throughout the tumor, but did not exceed peritumoral margins. In 10-day models treated with a single injection of TNF-E, HRP was found only in the tumor and immediate peritumoral regions while rTNF-alpha-treated rats showed more extensive areas of BBB breakdown with HRP evident throughout the entire right hemisphere and extending via the corpus callosum into the contralateral hemisphere. Pericapillary halos were also evident around the small blood vessels within the edematous areas of the corpus callosum. Within tumors, hemorrhagic necrosis and adherence of neutrophils to vessels was observed only in animals treated with rTNF-alpha at 10 days post-tumor inoculation. Multiple IV injections of rTNF-alpha in 7 and 10-day models triggered widespread hemorrhagic necrosis, neutrophil adherence and infiltration in the tumor. There was also extravasation and diffusion of HRP from the site of glioma into the contralateral hemisphere. Twelve-day models treated with multiple rTNF-alpha injections, in addition, showed irregular luminal surfaces and gaps between adjacent endothelial cells of tumor vasculature.(ABSTRACT TRUNCATED AT 400 WORDS)
研究了静脉注射人重组肿瘤坏死因子-α(rTNF-α,Cetus公司生产)对大鼠正常脑和恶性胶质瘤的影响。给12只Fischer 344大鼠单次注射10⁶U rTNF-α,或连续三天每天注射5×10⁵U rTNF-α。在注射rTNF-α后一天,给大鼠静脉注射辣根过氧化物酶(HRP)以测定血脑屏障(BBB)的破坏情况,一小时后,用醛类固定剂灌注并进行组织学检查。无论采用何种剂量或给药方案,用rTNF-α处理正常大鼠均未引起脑内明显的组织病理学变化,血脑屏障完整性也未改变。通过将10⁴个同基因RT-2胶质瘤细胞脑内接种到30只大鼠的右顶叶制作人类胶质瘤模型。在肿瘤接种后第3、7或10天,动物接受单次静脉注射10⁶U人rTNF-α或其赋形剂(TNF-E),或在肿瘤接种后第7、10或12天开始多次注射5×10⁵U rTNF-α。单次静脉注射rTNF-α或其赋形剂后,3天模型显示HRP外渗模式相似,仅限于肿瘤接种部位的细胞外间隙。在单次静脉注射rTNF-α或TNF-E处理的7天模型中,HRP在整个肿瘤内渗出,但未超过肿瘤周边。在单次注射TNF-E处理的10天模型中,HRP仅在肿瘤及其紧邻的周边区域发现,而rTNF-α处理的大鼠显示血脑屏障破坏区域更广泛,HRP在整个右半球均明显可见,并通过胼胝体延伸至对侧半球。在胼胝体水肿区域的小血管周围也可见毛细血管周围晕。在肿瘤内,仅在肿瘤接种后10天用rTNF-α处理的动物中观察到出血性坏死和中性粒细胞黏附于血管。在7天和10天模型中多次静脉注射rTNF-α引发肿瘤内广泛的出血性坏死、中性粒细胞黏附和浸润。此外,HRP还从胶质瘤部位外渗并扩散至对侧半球。多次注射rTNF-α处理的12天模型还显示肿瘤血管腔表面不规则,相邻内皮细胞之间有间隙。(摘要截短于400字)